Functional Genomic Analysis of the Response of HIV-1-Infected Lymphatic Tissue to Antiretroviral Therapy

Journal of Infectious Diseases

Volumn 189, Issue 4, 2004, Pages 572-582

  Li, Qingsheng ^a   Schacker, Timothy ^a   Carlis, John ^b   Beilman, Gregory ^a   Nguyen, Phuong ^a   Haase, Ashley T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DRUG EFFECT; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNITY; IMMUNOREACTIVITY; LYMPH NODE BIOPSY; MOLECULAR MODEL; PRIORITY JOURNAL; RETROVIRUS INFECTION; TISSUE REPAIR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY; DNA PRIMERS; GENOMICS; HIV INFECTIONS; HIV-1; LYMPH NODES; LYMPHOID TISSUE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, VIRAL;

EID: 1442349729     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/381396     Document Type: Article

References (43)

1. + T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol 1999; 17:625-56.
2. Haase AT, Henry K, Zupanic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996; 274:985-9.
3. + T cells. Science 1999; 286:1353-7.
4. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci USA 1998; 95:1154-9.
5. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997; 276:960-4.
6. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001; 410:980-7.
7. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-34.
8. Schacker TW, Nguyen PL, Beilman GJ, et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002; 110:1133-9.
9. Gretz JE, Kaldjian EP, Anderson AO, Shaw S. Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. J Immunol 1996; 157:495-9.
10. Zhang ZQ, Schuler T, Cavert W, et al. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Nat Acad Sci USA 1999; 96:5169-72.
11. + T cells. Eur J Immunol 2002; 32:1080-9.
12. Butte AJ, Ye J, Niederfellner G, et al. Determining significant fold differences in gene expression analysis. Pac Symp Biocomput 2001; 16: 6-17.
13. Levy DE, Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001; 12:143-56.
14. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-21.
15. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19:623-55.
16. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 1998; 273:29210-7.
17. Tissot C, Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 1995; 270:14891-8.
18. Schott K, Gutlich M, Ziegler I. Induction of GTP-cyclohydrolase I mRNA expression by lectin activation and interferon-gamma treatment in human cells associated with the immune response. J Cell Physiol 1993; 156:12-6.
19. Workman CJ, Dugger KJ, Vignali DAA. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immun 2002; 169:5392-5.
20. Högger P, Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 2001; 288:841-3.
21. Furuta GT, Turner JR, Taylor CT, et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001; 193:1027-34.
22. Halfon S, Ford J, Foster J, et al. Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J Biol Chem 1998; 273: 16400-8.
23. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002; 30(Suppl 5): S294-301.
24. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996; 76:69-125.
25. Dormady SP, Bashayan O, Dougherty R, Zhang XM, Basch RS. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res 2001; 10:125-40.
26. Goerdt S, Politz O, Schledzewski K, et al. Alternative versus classical activation of macrophages. Pathobiology 1999; 67:222-6.
27. Stumpo R, Kauer M, Martin S, Kolb H. Alternative activation of macrophage by IL-10. Pathobiology 1999; 67:245-8.
28. Chesney J, Metz C Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999; 5:181-91.
29. Gruber BL, Kew RR, Jelaska A, et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immun 1997; 158:2310-7.
30. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4:208-14.
31. + lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999; 103:1391-8.
32. Andrew DP, Ruffing N, Kim CH, et al. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 2001; 166:103-11.
33. Kaiser E, Forster R, Wolf I, Ebensperger C, Kueh WM, Lipp M. The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues. Eur J Immunol 1993; 23:2532-9.
34. Golay J, Capucci A, Arsura M, Castellano M, Rizzo V, Introna M. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 1991; 77:149-58.
35. Meyer KB, Skogberg M, Margenfeld C, Ireland J, Pettersson S. Repression of the immunoglobulin heavy chain 3′ enhancer by helix-loop-helix protein Id3 via a functionally important E47/E12 binding site: implications for developmental control of enhancer function. Eur J Immunol 1995; 25:1770-7.
36. Qi CF, Jessberger R, Torrey TA, Taddesse-Heath L, Ohta Y, Morrse HC 3rd. Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS. Mol Immunol 1999; 36:1043-53.
37. Teitell M, Damore MA, Sulur GG, et al. TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. Proc Natl Acad Sci USA 1999; 96:9809-14.
38. Ironson G, Balbin E, Solomon G, et al. Relative preservation of natural killer cell cytotoxicity and number of healthy AIDS patients with low CD4 cell counts. AIDS 2001; 15:2065-73.
39. Cohen GB, Gandhi RT, Davis DM, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661-71.
40. Vance RE, Jamieson AM, Raulet DH. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/ NKG2E on mouse natural killer cells. J Exp Med 1999; 190:1801-12.
41. + T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol 2002; 76:569-81.
42. Feinberg MB. Changing the natural history of HIV disease. Lancet 1996; 348:239-46.
43. Miyajima A, Ito K, Asano T, Seta K, Ueda A, Hayakawa M. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? J Urol 2001; 166:1124-9.